Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/2012
09/12/2012CN101244039B Novel method for preparing indissoluble medicaments liposome preparations
09/12/2012CN101229317B Medicine for removing heat-phlegm, relieving cough, and moistening lung and preparing method thereof
09/12/2012CN101204445B Soft capsule for hepatitis and preparation method thereof
09/12/2012CN101108826B Method for normal-temperature high-pressure aconine extracting and formulated product thereof
09/12/2012CN100998787B Traditional Chinese medicine effervescent tablets for treating gastrointestinal disease and its preparing method
09/11/2012US8263664 pH-sensitive polymeric micelles for drug delivery
09/11/2012US8263650 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
09/11/2012US8263647 Treatment of sleep disturbances
09/11/2012US8263600 Antifungal composition with enhanced bioavailability
09/11/2012US8263582 Administering two separate dosage forms of a topically active corticosteroid or a pharmaceutically active salt thereof for therapy ofinflammatory bowel disease and sufficient to reduce or eliminate side effects
09/11/2012US8263580 Vitamin formulation
09/11/2012US8263567 A lipophilic anthracycline with a pharmaceutically acceptable carrier for topical administration to a body surface and which has a higher lipophilicity than doxorubicin; valrubicin applied to mucous membranes; psoriasis; side effect reduction; not doxorubicin, daunorubicin, epirubicin or idarubicin
09/11/2012US8263565 Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same
09/11/2012US8263561 Composition and method for inhibiting, preventing, or ameliorating complications associated with ingestion of a medicinal, chemical, or biological substance or agent
09/11/2012US8263394 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides, and uses thereof
09/11/2012US8263133 Multivalent clustering targeting strategy for drug carriers
09/11/2012US8263132 Methods for preparing pharmaceuticals by emulsion aggregation processes
09/11/2012US8263131 Method for treating infectious organisms normally considered to be resistant to an antimicrobial drug
09/11/2012US8263130 Hollow sphere from amphiphilic chitosan derivatives and method of preparing amiphiphilic chitosan derivative complex for medical use
09/11/2012US8263129 Methods for fabricating isolated micro-and nano-structures using soft or imprint lithography
09/11/2012US8263128 Solid pharmaceutical dispersions with enhanced bioavailability
09/11/2012US8263127 Photochemical activation of surfaces for attaching biomaterial
09/11/2012US8263126 Orally-dispersible multilayer tablet
09/11/2012US8263125 Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients
09/11/2012US8263124 Anthistamine-decongestant pharmaceutical compositions
09/11/2012US8263123 Rapidly disintegrating tablet containing polyvinyl alcohol
09/11/2012US8263122 Wet granulation using a water sequestering agent
09/11/2012US8263121 Solid pharmaceutical preparation
09/11/2012US8263120 Oral antimicrobial pharmaceutical compositions
09/11/2012US8263119 Capsule formulations containing lanthanum compounds
09/11/2012US8263118 Bioresorbable fillers constituted by phospholipid liposomes and hyaluronic acid and/or the derivatives thereof
09/11/2012US8263117 C70-containing liposome, method for producing the same, and use of the same
09/11/2012US8263114 mixture of silicone fluid , silica and drug; wound dressing; topical applying; drug delivery
09/11/2012US8263112 In vivo use of water absorbent polymers
09/11/2012US8263111 Non-hormonal vaginal contraceptive
09/11/2012US8263110 Biocompatible intraocular implants include a steroid and a polymer associated with each other to facilitate release of the steroid into an eye for a period of time greater than about two months. The steroid mmatrix of a two biodegradable polymer matrix
09/11/2012US8263108 Biodegradable insert; drug delivery
09/11/2012US8263102 Drug delivery coating for use with a stent
09/11/2012US8263097 Methods and compositions for treating acne
09/11/2012US8263093 Methods and compositions for administration of TRPV1 agonists
09/11/2012US8263059 Compositions and kits for the removal of irritating compounds from bodily surfaces
09/11/2012US8263046 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical
09/11/2012US8263045 Sunless tanning composition and method of sunless tanning
09/11/2012US8263044 Stilbene like compounds as novel HDAC inhibitors
09/11/2012CA2596679C Method of treating ischemia-reperfusion injury
09/11/2012CA2592991C Nanoparticles for protein drug delivery
09/11/2012CA2588732C External patches containing etofenamate
09/11/2012CA2587280C Particle-size reduction apparatus, and use thereof
09/11/2012CA2561167C Composition of solifenacin or salt thereof for use in solid formulation
09/11/2012CA2540040C Rapidly disintegrating formulation
09/11/2012CA2533792C Medicaments for inhalation comprising steroids and fluorene carboxylic acid esters
09/11/2012CA2532450C Chlorthalidone combinations
09/11/2012CA2526570C Aqueous solution of olanexidine, method of preparing the aqueous solution, and disinfectant
09/11/2012CA2499979C Immediate release dosage form comprising shell having openings therein
09/11/2012CA2478558C Naltrexone hydrochloride compositions
09/11/2012CA2475218C Preparation for oxidation-sensitive compounds and method for making same
09/11/2012CA2467275C Method for preparing gels
09/11/2012CA2466851C Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositions
09/07/2012WO2012119151A2 Method and apparatus for alcohol administration
09/07/2012WO2012119117A1 Vesicle compositions
09/07/2012WO2012119102A2 Homeopathic therapeutic method and compositions
09/07/2012WO2012119070A2 Silicone-based ophthalmic formulations
09/07/2012WO2012119059A1 Non-aqueous silicone-based ophthalmic formulations
09/07/2012WO2012118930A2 Stable colloidal gold nanoparticles with controllable surface modification and functionalization
09/07/2012WO2012118857A2 Immunologically modified carbon nanotubes for cancer treatment
09/07/2012WO2012118794A2 Treatment of urinary incontinence using nitrone spin traps
09/07/2012WO2012118376A1 Advanced active liposomal loading of poorly water-soluble substances
09/07/2012WO2012118194A1 Pre-filled syringe filling syringe having resin barrel with aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118192A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118191A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118190A1 Aqueous solution containing hyaluronic acid or salt thereof
09/07/2012WO2012118180A1 Laminated tablet and manufacturing method therefor
09/07/2012WO2012117971A1 Lipid membrane structure, lipid membrane structure production method, and method for encapsulating one of the target substance with a single lipid membrane
09/07/2012WO2012117909A1 Manufacturing method for o/w emulsion composition
09/07/2012WO2012117587A1 Method for producing lipid structure
09/07/2012WO2012117385A2 Liposome formulation comprising an anti-tumour active substance, method for its preparation and pharmaceutical compositions comprising it
09/07/2012WO2012117362A1 Stable compositions of tetrahydrobiopterin
09/07/2012WO2012117257A1 Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer
09/07/2012WO2012117236A1 Vitamin d composition
09/07/2012WO2012117140A1 Thermosensitive compound for the controlled release of active or indicator substances
09/07/2012WO2012117115A2 Use of a viscoelastic fluid for producing a medicinal product for surgically treating the eye
09/07/2012WO2012116976A1 Prucalopride oral solution
09/07/2012WO2012116941A1 Producing powdery coating agents for stable protective coatings for pharmaceutical dosage forms
09/07/2012WO2012116940A1 Producing powdery coating agents for stable protective coatings for pharmaceutical dosage forms
09/07/2012WO2012116814A1 Coated solid pharmaceutical preparation
09/07/2012WO2012116811A1 Vaccination in elderly patients
09/07/2012WO2012116810A1 Vaccination in newborns and infants
09/07/2012WO2012116744A1 Chemical composition with hydrogen peroxide and a nanoemulsion of long-chained alcohols
09/07/2012WO2012116715A1 Vaccination in newborns and infants
09/07/2012WO2012116714A1 Vaccination in elderly patients
09/07/2012WO2012116507A1 Traditional chinese medicine perfusate for treating cow mastitis and preparation method thereof
09/07/2012WO2012116445A1 Chewable vehicle for mouth absorption
09/07/2012WO2012116434A1 Two speed monolithic system for controlled release of drugs
09/07/2012WO2012116402A1 Binder powders
09/07/2012WO2012094360A3 Biotherapeutics for the treatment of infectious diseases
09/07/2012WO2012092421A3 Composition for intravascular delivery of therapeutic composition
09/07/2012WO2012091153A3 Orally disintegrating tablet
09/07/2012WO2012082658A3 Antimicrobial ultrasound transmission gel or couplant
09/07/2012WO2012080833A3 Controlled release dosage forms
09/07/2012WO2012076907A3 Dosage form
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 2991